Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)

Condition:   ADHD Intervention:   Drug: Amphetamine Extended Release (ER) Tablet 20 mg Sponsors:   Tris Pharma, Inc.;   Massachusetts General Hospital;   Massachusetts Institute of Technology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials